Levothyroxine detailed information

Revision as of 16:52, 9 August 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Levothyroxine detailed information
Clinical data
Pregnancy
category
  • A (FDA)
Routes of
administration
Oral, Intravenous
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability~100%
MetabolismMainly in liver, kidneys, brain and muscles
Elimination half-lifeca. 7 days (in hyperthyroidism 3-4 days, in hypothyroidism 9-10 days)
ExcretionThrough feces and urine
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC15H10I4NNaO4
Molar mass798.86 (anhydrous)

WikiDoc Resources for Levothyroxine detailed information

Articles

Most recent articles on Levothyroxine detailed information

Most cited articles on Levothyroxine detailed information

Review articles on Levothyroxine detailed information

Articles on Levothyroxine detailed information in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Levothyroxine detailed information

Images of Levothyroxine detailed information

Photos of Levothyroxine detailed information

Podcasts & MP3s on Levothyroxine detailed information

Videos on Levothyroxine detailed information

Evidence Based Medicine

Cochrane Collaboration on Levothyroxine detailed information

Bandolier on Levothyroxine detailed information

TRIP on Levothyroxine detailed information

Clinical Trials

Ongoing Trials on Levothyroxine detailed information at Clinical Trials.gov

Trial results on Levothyroxine detailed information

Clinical Trials on Levothyroxine detailed information at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Levothyroxine detailed information

NICE Guidance on Levothyroxine detailed information

NHS PRODIGY Guidance

FDA on Levothyroxine detailed information

CDC on Levothyroxine detailed information

Books

Books on Levothyroxine detailed information

News

Levothyroxine detailed information in the news

Be alerted to news on Levothyroxine detailed information

News trends on Levothyroxine detailed information

Commentary

Blogs on Levothyroxine detailed information

Definitions

Definitions of Levothyroxine detailed information

Patient Resources / Community

Patient resources on Levothyroxine detailed information

Discussion groups on Levothyroxine detailed information

Patient Handouts on Levothyroxine detailed information

Directions to Hospitals Treating Levothyroxine detailed information

Risk calculators and risk factors for Levothyroxine detailed information

Healthcare Provider Resources

Symptoms of Levothyroxine detailed information

Causes & Risk Factors for Levothyroxine detailed information

Diagnostic studies for Levothyroxine detailed information

Treatment of Levothyroxine detailed information

Continuing Medical Education (CME)

CME Programs on Levothyroxine detailed information

International

Levothyroxine detailed information en Espanol

Levothyroxine detailed information en Francais

Business

Levothyroxine detailed information in the Marketplace

Patents on Levothyroxine detailed information

Experimental / Informatics

List of terms related to Levothyroxine detailed information


Levothyroxine, also known as L-thyroxine, synthetic T4 or 3,5,3',5'-tetraiodo-L-thyronine, is a synthetic form of thyroxine (thyroid hormone). The natural hormone is chemically in the L-form, as is the pharmaceutical agent. Dextrothyroxine (D-thyroxine) briefly saw research as an anticholesterol agent but was pulled due to cardiac side-effects.

The EU has recently standardized the use of the name "levothyroxine" for the drug. Common brand names include ""Thyrax"", "Euthyrox", "Levaxin" and "Eltroxin" in Europe, and "Levoxyl" and "Synthroid" in the U.S. There are also numerous generic versions approved by the Food and Drug Administration.

Uses

This medicine is a hormone replacement usually given to patients with thyroid problems, specifically, hypothyroidism. It is also given to people who have Goitre or an enlarged thyroid gland.

Administration

It is recommended that levothyroxine be taken half an hour to an hour before meals to maximize its absorption. It is also recommended that the patient take the tablet with one glass of water to ease swallowing as well as to help the tablet dissolve for absorption.

Precautions and side effects

There are also foods and other substances that can interfere with absorption of thyroxine replacement. Avoid taking calcium and iron supplements within 4 hours of the medication and avoid taking soy products within 3 hours of the medication as these can reduce absorption of the medication.

Synthetic levothyroxine may have adverse side effects like: palpitations, nervousness, headache, difficulty sleeping, insomnia, swelling of the legs and ankles, weight loss and/or increased appetite. Some may be allergic to the medicine. If the patient develops a severe reaction to this drug like difficulty breathing, shortness of breath or swelling of the face and tongue it is imperative that the patient immediately seek medical attention.

Marketing and approvals

Levothyroxine 25mcg tablets

Synthroid is the most prescribed brand of T4 in United States. Synthroid was marketed in 1955,[1] but was not FDA approved at that time as it was considered "generally regarded safe". In the 1990s, in response to debate as to whether Synthroid was more effective than other levothyroxine preparations, (which ended up concluding that there was little difference between Synthroid and generic brands[2] all levothyroxine preparations were required to undergo the formal FDA approval process. Synthroid was approved by the FDA on 2002-07-24.[3]

References

External links

Template:Thyroid therapy

hu:Levotiroxin nl:Levothyroxine


Template:WikiDoc Sources